Cleverbridge
The product's easy-to-use dashboards empower companies to accurately benchmark and forecast performance, calculate robust customer health scores, and more.
COLOGNE, GERMANY / ACCESSWIRE / November 30, 2023 / Cleverbridge, a growth engine for global technology companies, today announced the launch of CleverInsights, an advanced analytics suite that leverages AI and 18+ years of eCommerce data to provide unparalleled visibility into recurring revenue, retention, and other essential subscription metrics.
Pre-built dashboards for benchmarking, forecasting, anomaly detection, and customer health scoring empower organizations to derive deep insights and optimize performance in near real-time amid an uncertain and ever-changing business environment. These features streamline the reporting process and eliminate the burden of manual and time-consuming analysis, allowing employees to focus on more complex or strategic tasks when most companies are struggling to do more with less.
"As a CEO, I know firsthand how important it is to have accurate reporting. I also know that analysis is resource-intensive, and that too often resulting information is inaccurate, stale, or communicated without the context of broader industry or macroeconomic trends," said Wendi Sturgis, Chief Executive Officer of Cleverbridge. "With CleverInsights, any organization can reliably monitor and optimize recurring revenue with insights that are truly actionable. This grants a distinct competitive advantage, empowers data-driven decision making, and further enables technology companies to grow without adding headcount."
CleverInsights addresses a critical business need with benchmarking and forecasting, two capabilities that help companies interpret and predict key figures tied to recurring revenue with industry-leading levels of accuracy. Organizations can leverage these insights as needed to narrow their strategic focus while other areas of the product run continuously in the background. Anomaly detection, for instance, identifies unexpected changes in key metrics and alerts users to fluctuations along with the probable root causes for spikes or dips, allowing organizations to take immediate action and correct potential issues.
The product's robust customer health scores are calculated with standard inputs along with transaction data such as payment date, payment method, and expansion percentage. These additional data points strengthen the accuracy of health scores and feed into renewal and expansion propensity models that facilitate the effective prioritization of accounts. CleverInsights then recommends the best course of action for each customer, giving organizations the option to trigger automated or semi-automated interventions by leveraging another new Cleverbridge product, CleverAutomations.
General availability of CleverInsights is expected early next year. For more information and to schedule a demo, please visit grow.cleverbridge.com/products/cleverinsights.
About Cleverbridge
Cleverbridge makes it easy to maximize customer lifetime value. We leverage deep eCommerce expertise to orchestrate and automate frictionless self-service transactions across the entire customer journey, empowering customers to purchase, renew, and expand subscriptions in 248 countries and territories globally. For more than 18 years, our Growth Engine has integrated payments with subscription management, lifecycle marketing automation, advanced analytics, and partner ecosystems to consistently deliver recurring revenue growth without added headcount. Learn more at grow.cleverbridge.com.
Contact Information
Gordon Knapp
Senior Director, Marketing
gordon.knapp@cleverbridge.com
+17573458523
SOURCE: Cleverbridge
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View source version on accesswire.com:
https://www.accesswire.com/811741/cleverbridge-launches-cleverinsights-to-deliver-accurate-ai-powered-analytics-for-subscription-businesses
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Charlie's Holdings (OTCQB:CHUC) Signs Agreement with IKE Tech to Commercialize Transformational Age-Gated Vapes that Will Address FDA Concerns Related to Youth Access12.1.2026 12:00:00 CET | Press release
SBX Product Line Will Feature First-Ever AI-Powered Blockchain-Based Age-Gating System for Vape Products IKE's patented biometric BLE Bluetooth chip and blockchain-based app will enable Charlie's to ensure that underage individuals will not be able to activate or utilize the Company's age-gated products. The IKE Licensing Agreement provides CHUC with a first mover advantage in youth access prevention (one of the FDA's top priorities) and a three-year exclusivity period for age-gated nicotine analogue products. Charlie's will test market the IKE age-gating system this spring with the Company's popular SBX nicotine analogue product line; simultaneously, Charlie's intends to incorporate the revolutionary technology into its PACHA branded Electronic Nicotine Delivery Systems (ENDS). COSTA MESA, CA / ACCESS Newswire / January 12, 2026 / Charlie's Holdings, Inc. (OTCQB:CHUC) ("Charlie's" or the "Company"), an industry leader in the premium vapor products space, today reported that the Compan
Datavault AI Celebrates Successful Completion of Dream Bowl XIV, Pioneering Blockchain Innovation in Sports Entertainment12.1.2026 12:00:00 CET | Press release
On January 10, 2026, a few dozen of NFL Alumni Greats (click here for a list of participating athletes) live-autographed 100 Footballs (click here to view the autographed NFL Alumni Footballs) and 500 Jerseys (click here to view the autographed NFL Alumni Jerseys); Starting on February 1, 2026, these special, one-time, live-autographed memorabilia items are to be given away by lottery to eligible holders of Dream Bowl Meme Coin I tokens and, following their distribution date (currently set for February 21, 2026), Dream Bowl Meme Coin II tokens and will be tradable on the upcoming International NIL Exchange; $25,000 E-Sports Scholarships Raised by Sponsors were Given to Dream Bowl Madden and Team E-Sports Champions; and 70 Student Star Athletes Showcased their Talent to USFL, NFL and European League Scouts (click here to view the Special Dream Bowl XIV Participants' Jerseys). PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 12, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI
PromiCell, Inc. presents during JP Morgan's 2026 Healthcare Conference9.1.2026 18:35:00 CET | Press release
MIAMI, FL / ACCESS Newswire / January 9, 2026 / PromiCell, Inc. (the "Company"), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell therapies for cancer patients, today announced that the Company's Chief Medical Officer, John Lee, MD, Ph.D., will present interim results of the Company's lead asset PRO CAR - 201A, a STEAP1 directed CAR T cell that is currently in the clinic as a first-in-human phase 1 trial for the treatment of metastatic castration-resistant prostate cancer (mCRPC), at Biotech Showcase 2026 in San Francisco, California on Monday, January 12, 2025 at 11:15 am PST at the Franciscan D (Ballroom Level). About PromiCell, Inc. PromiCell, is a clinical-stage cellular immunotherapy company with product candidates representing highly differentiated and novel CAR T and TCR T platforms to be developed across separate solid and hematologic types of cancer. Our pipeline of innovative products includes STEAP 1 CAR T cells, HA-1 T
Datavault AI Expands IBM Collaboration to Deploy Enterprise-Grade AI at the Edge with Available Infrastructure's SanQtum AI Platform8.1.2026 13:00:00 CET | Press release
Datavault AI will activate a secured multi-city edge AI network for real-time data tokenization, security, and monetization across New York and Philadelphia NEW YORK, NY / ACCESS Newswire / January 8, 2026 / Datavault AI Inc. (Nasdaq:DVLT), a leader in instant data monetization & enterprise digital twins, announced it will deliver enterprise-grade AI performance at the edge in New York and Philadelphia through an expanded collaboration with IBM using the SanQtum AI platform. Operated by Available Infrastructure, SanQtum AI is a fleet of synchronized micro edge data centers running IBM's watsonx portfolio of AI products on a zero-trust network. The combined deployment is designed to enable cybersecure data storage and compute, real-time data scoring, tokenization, and ultra-low-latency, across two of the most data-dense metro regions in the United States. By running Datavault AI's Information Data Exchange and DataScore agents - built with watsonx - within SanQtum AI's zero-trust edge e
Ascend Advanced Therapies - ABL Inc. Further Strengthens Executive Team as It Drives Forward an Ambitious Growth Strategy8.1.2026 13:00:00 CET | Press release
Seiga Ohmine to join as Chief Commercial Officer, Sharad Dubey as Chief Financial Officer and Patrick Lansky as Senior Vice President of Global Business Development Appointments underscore Ascend-ABL's commitment to scientific rigor, operational excellence, and strategic growth ROCKVILLE, MARYLAND / ACCESS Newswire / January 8, 2026 / Ascend Advanced Therapies - ABL Inc. today announced significant appointments to its leadership team. Seiga Ohmine Ph.D. joins as Chief Commercial Officer (CCO) Sharad Dubey CA, CPA joins as Chief Financial Officer (CFO) Patrick Lansky joins as Senior Vice President of Global Business Development These appointments reflect Ascend-ABL's focus on strengthening scientific leadership, operational discipline, and customer-centric execution as the company sharpens its positioning as a trusted CDMO partner for advanced viral modalities. Commenting on the appointments, Alessandra Rispoli, Chief Executive Officer of Ascend-ABL said, "We are making strong progress
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
